o Aardal E, Holm AC. Cortisol in saliva--reference ranges and relation to cortisol in serum. Eur J Clin Chem Clin Biochem. 1995;33(12):927-32.

(1)

REFERENCES.

o Aardal E, Holm AC. Cortisol in saliva--reference ranges and relation to cortisol in serum. Eur J Clin Chem Clin Biochem. 1995;33(12):927-32.

o Aardal-Eriksson E, Eriksson TE, Thorell LH. Salivary cortisol, posttraumatic stress symptoms, and general health in the acute phase and during 9-month follow-up. Biol Psychiatry. 2001;50(12):986-93.

o Adamec RE, Burton P, Shallow T, Budgell J. NMDA receptors mediate lasting increases in anxiety-like behavior produced by the stress of predator exposure-- implications for anxiety associated with posttraumatic stress disorder. Physiol Behav. 1999;65(4-5):723-37.

o Adamec RE, Burton P, Shallow T, Budgell J. Unilateral block of NMDA receptors in the amygdala prevents predator stress-induced lasting increases in anxiety-like behavior and unconditioned startle--effective hemisphere depends on the behavior. Physiol Behav. 1999;65(4-5):739-51.

o Adamec RE. Evidence that limbic neural plasticity in the right hemisphere mediates partial kindling induced lasting increases in anxiety-like behavior:

effects of low frequency stimulation (quenching?) on long term potentiation of amygdala efferents and behavior following kindling. Brain Res.

1999;839(1):133-52.

o Aerni A, Traber R, Hock C, Roozendaal B, Schelling G, Papassotiropoulos A, Nitsch RM, Schnyder U, de Quervain DJ. Low-dose cortisol for symptoms of posttraumatic stress disorder. Am J Psychiatry. 2004;161(8):1488-90.

o Akwa Y, Purdy RH, Koob GF, Britton KT. The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat. Behav Brain Res. 1999;106(1-2):119-25.

o Akwa Y, Young J, Kabbadj K, Sancho MJ, Zucman D, Vourc'h C, Jung-Testas I, Hu ZY, Le Goascogne C, Jo DH, et al. Neurosteroids: biosynthesis, metabolism and function of pregnenolone and dehydroepiandrosterone in the brain. J Steroid Biochem Mol Biol. 1991;40(1-3):71-81.

o Altemus M, Cloitre M, Dhabhar FS. Enhanced cellular immune response in women with PTSD related to childhood abuse. Am J Psychiatry.

2003;160(9):1705-7.

o Anholt RR, De Souza EB, Kuhar MJ, Snyder SH. Depletion of peripheral-type benzodiazepine receptors after hypophysectomy in rat adrenal gland and testis.

Eur J Pharmacol. 1985;110(1):41-6.

o Anholt RR, De Souza EB, Oster-Granite ML, Snyder SH. Peripheral-type benzodiazepine receptors: autoradiographic localization in whole-body sections of neonatal rats. J Pharmacol Exp Ther. 1985;233(2):517-26.

o Anholt RR, Pedersen PL, De Souza EB, Snyder SH. The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J Biol Chem. 1986;261(2):576-83.

o Antkiewicz-Michaluk L, Guidotti A, Krueger KE. Molecular characterization and mitochondrial density of a recognition site for peripheral-type benzodiazepine ligands. Mol Pharmacol. 1988;34(3):272-8.

o Antkiewicz-Michaluk L, Mukhin AG, Guidotti A, Krueger KE. Purification and

characterization of a protein associated with peripheral-type benzodiazepine

binding sites. J Biol Chem. 1988;263(33):17317-21.

(2)

o Armario A. The hypothalamic-pituitary-adrenal axis: what can it tell us about stressors? CNS Neurol Disord Drug Targets. 2006;5(5):485-501. Review

o Aurer A, Aurer-Kozelj J, Stavljenić-Rukavina A, Kalenić S, Ivić-Kardum M, Haban V. Inflammatory mediators in saliva of patients with rapidly progressive periodontitis during war stress induced incidence increase. Coll Antropol.

1999;23(1):117-24.

o Avital A, Richter-Levin G, Leschiner S, Spanier I, Veenman L, Weizman A, Gavish M. Acute and repeated swim stress effects on peripheral benzodiazepine receptors in the rat hippocampus, adrenal, and kidney.

Neuropsychopharmacology. 2001;25(5):669-78.

o Baard E. The Guilt-Free Soldier, The Village Voice January 28, 2003;

http://www.biopsychiatry.com/misc/guiltfree.html.

o Baker DG, West SA, Nicholson WE, Ekhator NN, Kasckow JW, Hill KK, Bruce AB, Orth DN, Geracioti TD Jr. Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am J Psychiatry. 1999;156(4):585-8. Erratum in: Am J Psychiatry 1999;156(6):986.

o Balestrieri M, Rucci P, Sbrana A, Ravani L, Benvenuti A, Gonnelli C, Dell'osso L, Cassano GB. Lifetime rhythmicity and mania as correlates of suicidal ideation and attempts in mood disorders. Compr Psychiatry. 2006;47(5):334-41.

o Bar-Ami S, Fares F, Gavish M. Effect of hypophysectomy and hormone treatment on the induction of peripheral-type benzodiazepine binding sites in female rat genital axis. Horm Metab Res. 1989;21(2):106-7.

o Barco A, Pittenger C, Kandel ER. CREB, memory enhancement and the treatment of memory disorders: promises, pitfalls and prospects. Expert Opin Ther Targets. 2003;7(1):101-14. Review.

o Bastianetto S, Ramassamy C, Poirier J, Quirion R. Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res Mol Brain Res. 1999;66(1-2):35-41.

o Baulieu EE, Robel P. Dehydroepiandrosterone and dehydroepiandrosterone sulfate as neuroactive neurosteroids. J Endocrinol. 1996;150:S221-39. Review.

o Bazzichi L, Maser J, Piccinni A, Rucci P, Del Debbio A, Vivarelli L, Catena M, Bouanani S, Merlini G, Bombardieri S, Dell'Osso L. Quality of life in rheumatoid arthritis: impact of disability and lifetime depressive spectrum symptomatology.

Clin Exp Rheumatol. 2005;23(6):783-8.

o Belanoff JK, Gross K, Yager A, Schatzberg AF. Corticosteroids and cognition. J Psychiatr Res. 2001;35(3):127-45. Review.

o Belanoff JK, Kalehzan M, Sund B, Fleming Ficek SK, Schatzberg AF. Cortisol activity and cognitive changes in psychotic major depression. Am J Psychiatry.

2001;158(10):1612-6.

o Belelli D, Lambert JJ. Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat Rev Neurosci. 2005;6(7):565-75. Review.

o Berry FB. The post Vietnam syndrome. Med Times. 1972;100(11):33.

o Bessler H, Caspi B, Gavish M, Rehavi M, Hart J, Weizman R. Peripheral-type

benzodiazepine receptor ligands modulate human natural killer cell activity. Int J

Immunopharmacol. 1997;19(5):249-54.

(3)

o Bessler H, Caspi B, Gavish M, Rehavi M, Weizman A. Significant inhibition of spontaneous IgA secretion by selective peripheral-type benzodiazepine receptor ligands. Clin Neuropharmacol. 1997;20(3):215-23.

o Bessler H, Weizman R, Gavish M, Notti I, Djaldetti M. Immunomodulatory effect of peripheral benzodiazepine receptor ligands on human mononuclear cells. J Neuroimmunol. 1992;38(1-2):19-25.

o Betti L, Giannaccini G, Nigro M, Dianda S, Gremigni V, Lucacchini A. Studies of peripheral benzodiazepine receptors in mussels: comparison between a polluted and a nonpolluted site. Ecotoxicol Environ Saf. 2003;54(1):36-42.

o Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, Pütz B, Papiol S, Seaman S, Lucae S, Kohli MA, Nickel T, Künzel HE, Fuchs B, Majer M, Pfennig A, Kern N, Brunner J, Modell S, Baghai T, Deiml T, Zill P, Bondy B, Rupprecht R, Messer T, Köhnlein O, Dabitz H, Brückl T, Müller N, Pfister H, Lieb R, Mueller JC, Lõhmussaar E, Strom TM, Bettecken T, Meitinger T, Uhr M, Rein T, Holsboer F, Muller-Myhsok B. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet. 2004;36(12):1319-25.

o Bitran D, Shiekh M, McLeod M. Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors. J Neuroendocrinol. 1995;7(3):171-7.

o Blahos J 2nd, Whalin ME, Krueger KE. Identification and purification of a 10- kilodalton protein associated with mitochondrial benzodiazepine receptors. J Biol Chem. 1995;270(35):20285-91.

o Blendy JA. The role of CREB in depression and antidepressant treatment. Biol Psychiatry. 2006;59(12):1144-50. Review.

o Blundell J, Adamec R. Elevated pCREB in the PAG after exposure to the elevated plus maze in rats previously exposed to a cat. Behav Brain Res.

2006;175(2):285-95.

o Bohus MJ, Landwehrmeyer GB, Stiglmayr CE, Limberger MF, Böhme R, Schmahl CG. Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: an open-label trial. J Clin Psychiatry.

1999;60(9):598-603.

o Bono F, Lamarche I, Prabonnaud V, Le Fur G, Herbert JM. Peripheral benzodiazepine receptor agonists exhibit potent antiapoptotic activities. Biochem Biophys Res Commun. 1999;265(2):457-61.

o Boscarino JA, Chang J. Higher abnormal leukocyte and lymphocyte counts 20 years after exposure to severe stress: research and clinical implications.

Psychosom Med. 1999;61(3):378-86.

o Bossini L, Tavanti M, Calossi S, Lombardelli A, Polizzotto NR, Galli R, Vatti G, Pieraccini F, Castrogiovanni P. Magnetic resonance imaging volumes of the hippocampus in drug-naïve patients with post-traumatic stress disorder without comorbidity conditions. J Psychiatr Res. 2007 [Epub ahead of print]

o Bourtchuladze R, Frenguelli B, Blendy J, Cioffi D, Schutz G, Silva AJ. Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell. 1994;79(1):59-68.

o Böyum A. Isolation of leucocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent.

Scand J Clin Lab Invest Suppl. 1968;97:9-29.

o Boyum A. Isolation of mononuclear cells and granulocytes from human blood.

Isolation of monuclear cells by one centrifugation and of granulocytes by

(4)

combining centrifugation and sedimentation at 1 g. Scandinavian Journal of Clinical and Laboratory Investigation Supplementum 1968;97:77-89.

o Braestrup C, Squires RF. Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H) diazepam binding. Proc Natl Acad Sci U S A.

1977;74(9):3805-9.

o Brambilla F, Biggio G, Pisu MG, Bellodi L, Perna G, Bogdanovich-Djukic V, Purdy RH, Serra M. Neurosteroid secretion in panic disorder. Psychiatry Res.

2003;118(2):107-16.

o Brambilla P, Perez J, Barale F, Schettini G, Soares JC. GABAergic dysfunction in mood disorders. Mol Psychiatry. 2003;8(8):721-37, 715. Review.

o Bremner JD, Elzinga B, Schmahl C, Vermetten E. Structural and functional plasticity of the human brain in posttraumatic stress disorder. Prog Brain Res.

2008;167:171-86. Review.

o Bremner JD, Krystal JH, Southwick SM, Charney DS. Functional neuroanatomical correlates of the effects of stress on memory. J Trauma Stress.

1995;8(4):527-53. Review.

o Bremner JD, Licinio J, Darnell A, Krystal JH, Owens MJ, Southwick SM, Nemeroff CB, Charney DS. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry.

1997;154(5):624-9.

o Bremner JD, Randall P, Scott TM, Bronen RA, Seibyl JP, Southwick SM, Delaney RC, McCarthy G, Charney DS, Innis RB. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry. 1995;152(7):973-81.

o Bremner JD, Randall P, Vermetten E, Staib L, Bronen RA, Mazure C, Capelli S, McCarthy G, Innis RB, Charney DS. Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse—a preliminary report. Biol Psychiatry.

1997;41(1):23-32.

o Bremner JD, Scott TM, Delaney RC, Southwick SM, Mason JW, Johnson DR, Innis RB, McCarthy G, Charney DS. Deficits in short-term memory in posttraumatic stress disorder. Am J Psychiatry. 1993;150(7):1015-9.

o Bremner JD, Southwick SM, Johnson DR, Yehuda R, Charney DS. Childhood physical abuse and combat-related posttraumatic stress disorder in Vietnam veterans. Am J Psychiatry. 1993;150(2):235-9.

o Bremner JD, Steinberg M, Southwick SM, Johnson DR, Charney DS. Use of the Structured Clinical Interview for DSM-IV Dissociative Disorders for systematic assessment of dissociative symptoms in posttraumatic stress disorder. Am J Psychiatry. 1993;150(7):1011-4.

o Bremner JD. Neuroimaging in posttraumatic stress disorder and other stress- related disorders. Neuroimaging Clin N Am. 2007;17(4):523-38, ix. Review.

o Bremner JD. Neuroimaging studies in post-traumatic stress disorder. Curr Psychiatry Rep. 2002;4(4):254-63. Review.

o Brinton RD. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one induces cytoarchitectural regression in cultured fetal hippocampal neurons. J Neurosci.

1994;14:2763-74.

o Bruijnzeel AW, Stam R, Croiset G, Wiegant VM. Long-term sensitization of cardiovascular stress responses after a single stressful experience. Physiol Behav.

2001;73(1-2):81-6.

(5)

o Butterfield MI, Stechuchak KM, Connor KM, Davidson JR, Wang C, MacKuen CL, Pearlstein AM, Marx CE. Neuroactive steroids and suicidality in posttraumatic stress disorder. Am J Psychiatry. 2005;162(2):380-2.

o Campfield KM, Hills AM. Effect of timing of critical incident stress debriefing (CISD) on posttraumatic symptoms. J Trauma Stress. 2001;14(2):327-40.

o Cardounel A, Regelson W, Kalimi M. Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: mechanism of action. Proc Soc Exp Biol Med. 1999;222(2):145-9.

o Carlezon WA Jr, Duman RS, Nestler EJ. The many faces of CREB. Trends Neurosci. 2005;28(8):436-45. Review.

o Carmel I, Fares FA, Leschiner S, Scherübl H, Weisinger G, Gavish M.

Peripheral-type benzodiazepine receptors in the regulation of proliferation of MCF-7 human breast carcinoma cell line. Biochem Pharmacol. 1999;58(2):273- 8.

o Carpenter WT Jr, Gruen PH. Cortisol's effects on human mental functioning. J Clin Psychopharmacol. 1982;2(2):91-101. Review.

o Cassano GB, Dell'Osso L, Frank E, Miniati M, Fagiolini A, Shear K, Pini S, Maser J. The bipolar spectrum: a clinical reality in search of diagnostic criteria and an assessment methodology. J Affect Disord. 1999 Aug;54(3):319-28.

Review

o Cassano GB, Michelini S, Shear MK, Coli E, Maser JD, Frank E. The panic- agoraphobic spectrum: a descriptive approach to the assessment and treatment of subtle symptoms. Am J Psychiatry. 1997;154(6 Suppl):27-38. Review.

o Cassano GB, Pini S, Saettoni M, Dell'Osso L. Multiple anxiety disorder comorbidity in patients with mood spectrum disorders with psychotic features.

Am J Psychiatry. 1999;156(3):474-6.

o Cassano GB, Rucci P, Frank E, Fagiolini A, Dell'Osso L, Shear MK, Kupfer DJ.

The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach. Am J Psychiatry. 2004;161(7):1264-9.

o Charney DS, Deutch AY, Krystal JH, Southwick SM, Davis M. Psychobiologic mechanisms of posttraumatic stress disorder. Arch Gen Psychiatry.

1993;50(4):295-305. Review.

o Chelli B, Falleni A, Salvetti F, Gremigni V, Lucacchini A, Martini C. Peripheral- type benzodiazepine receptor ligands: mitochondrial permeabilità transition induction in rat cardiac tissue. Biochem Pharmacol. 2001;61(6):695-705.

o Chelli B, Lena A, Vanacore R, Da Pozzo E, Costa B, Rossi L, Salvetti A, Scatena F, Ceruti S, Abbracchio MP, Gremigni V, Martini C. Peripheral benzodiazepine receptor ligands: mitochondrial transmembrane potential depolarization and apoptosis induction in rat C6 glioma cells. Biochem Pharmacol. 2004;68(1):125- 34.

o Chelli B, Pini S, Abelli M, Cardini A, Lari L, Muti M, Gesi C, Cassano GB, Lucacchini A, Martini C. Platelet 18 kDa Translocator Protein density is reduced in depressed patients with adult separation anxiety. Eur Neuropsychopharmacol.

2008;18(4):249-54.

o Chrivia JC, Kwok RP, Lamb N, Hagiwara M, Montminy MR, Goodman RH.

Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature.

1993;365(6449):855-9.

o Collins JW. The neuroscience of learning. J Neurosci Nurs. 2007;39(5):305-10.

Review.

(6)

o Compagnone NA, Mellon SH. Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development. Proc Natl Acad Sci U S A. 1998;95(8):4678-83.

o Corcoran C, Walker E, Huot R, Mittal V, Tessner K, Kestler L, Malaspina D. The stress cascade and schizophrenia: etiology and onset. Schizophr Bull.

2003;29(4):671-92. Review.

o Corpéchot C, Baulieu EE, Robel P. Testosterone, dihydrotestosterone and androstanediols in plasma, testes and prostates of rats during development. Acta Endocrinol (Copenh). 1981;96(1):127-35.

o Corpéchot C, Robel P, Axelson M, Sjövall J, Baulieu EE. Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc Natl Acad Sci U S A. 1981;78(8):4704-7.

o Costa B, Salvetti A, Rossi L, Spinetti F, Lena A, Chelli B, Rechichi M, Da Pozzo E, Gremigni V, Martini C. Peripheral benzodiazepine receptor: characterization in human T-lymphoma Jurkat cells. Molecular Pharmacology 2006;69:37-44.

o Culty M, Li H, Boujrad N, Amri H, Vidic B, Bernassau JM, Reversat JL, Papadopoulos V. In vitro studies on the role of the peripheral-type benzodiazepine receptor in steroidogenesis. J Steroid Biochem Mol Biol.

1999;69(1-6):123-30. Review.

o Dallman MF. Fast glucocorticoid actions on brain: back to the future. Front Neuroendocrinol. 2005;26(3-4):103-8. Review.

o Daly RC, Schmidt PJ, Davis CL, Danaceau MA, Rubinow DR. Effects of gonadal steroids on peripheral benzodiazepine receptor density in women with PMS and controls. Psychoneuroendocrinology. 2001;26(6):539-49.

o Dar D, Weizman A, Karp L, Grinshpoon A, Bidder M, Kotler M, Tyano S, Bleich A, Gavish M. Platelet peripheral benzodiazepine receptors in repeated stress.

Life Sciences 1991;48:341–346.

o Darves-Bornoz JM, Lemperiere T, Degiovanni A, Sauvage D, Gaillard P.

Psychotic women and their children. Annales Médico-Psychologiques 1995;153:286-289.

o Davis LL, Clark DM, Kramer GL, Moeller FG, Petty F. D-fenfluramine challenge in posttraumatic stress disorder.Biol Psychiatry. 1999;45(7):928-30.

o Davis M. The role of the amygdala in fear and anxiety. Annu Rev Neurosci.

1992;15:353-75. Review.

o Davis M. The role of the amygdala in fear-potentiated startle: implications for animal models of anxiety.Trends Pharmacol Sci. 1992;13(1):35-41. Review.

o De Bellis MD, Baum AS, Birmaher B, Keshavan MS, Eccard CH, Boring AM, Jenkins FJ, Ryan ND. A.E. Bennett Research Award. Developmental traumatology. Part I: Biological stress systems. Biol Psychiatry.

1999;45(10):1259-70. Review.

o de Bruin VM, Vieira MC, Rocha MN, Viana GS. Cortisol and dehydroepiandosterone sulfate plasma levels and their relationship to aging, cognitive function, and dementia. Brain Cogn. 2002;50(2):316-23.

o de Kloet CS, Vermetten E, Geuze E, Kavelaars A, Heijnen CJ, Westenberg HG.

Assessment of HPA-axis function in posttraumatic stress disorder:

pharmacological and non-pharmacological challenge tests, a review. J Psychiatr Res. 2006;40(6):550-67.

o de Kloet ER, Joëls M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci. 2005;6(6):463-75. Review.

o de Kloet ER, Vreugdenhil E, Oitzl MS, Joëls M. Brain corticosteroid receptor

balance in health and disease. Endocr Rev. 1998;19(3):269-301. Review.

(7)

o Delahanty DL, Raimonde AJ, Spoonster E. Initial posttraumatic urinary cortisol levels predict subsequent PTSD symptoms in motor vehicle accident victims.

Biol Psychiatry. 2000;48(9):940-7.

o Delia Belelli & Jeremy J. Lambert. Neurosteroids: endogenous regulators of the GABA

A

receptor. Nature Reviews Neuroscience 2005;6:565-575.

o Dell'Osso L, Armani A, Rucci P, Frank E, Fagiolini A, Corretti G, Shear MK, Grochocinski VJ, Maser JD, Endicott J, Cassano GB. Measuring mood spectrum:

comparison of interview (SCI-MOODS) and self-report(MOODS-SR) instruments. Compr Psychiatry. 2002;43(1):69-73.

o Dell'osso L, Shear MK, Carmassi C, Rucci P, Maser JD, Frank E, Endicott J, Lorettu L, Altamura CA, Carpiniello B, Perris F, Conversano C, Ciapparelli A, Carlini M, Sarno N, Cassano GB Validity and reliability of the Structured Clinical Interview for the Trauma and Loss Spectrum (SCI-TALS). Clin Pract Epidemol Ment Health. 2008;4:2.

o Demirgören S, Majewska MD, Spivak CE, London ED. Receptor binding and electrophysiological effects of Dehydroepiandrosterone sulfate, an antagonist of the GABAA receptor. Neuroscience. 1991;45(1):127-35.

o Di S, Malcher-Lopes R, Halmos KC, Tasker JG. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci. 2003;23(12):4850-7.

o Dolder M, Wendt S, Wallimann T. Mitochondrial creatine kinase in contact sites:

interaction with porin and adenine nucleotide translocase, role in permeability transition and sensitivity to oxidative damage. Biol Signals Recept. 2001;10(1- 2):93-111. Review.

o Droogleever Fortuyn HA, van Broekhoven F, Span PN, Bäckström T, Zitman FG, Verkes RJ. Effects of PhD examination stress on allopregnanolone and cortisol plasma levels and peripheral benzodiazepine receptor density.

Psychoneuroendocrinology. 2004;29(10):1341-4.

o Drugan RC, Park R, Kaufman L, Holmes PV. Etiology of the sexual dimorphism in renal peripheral benzodiazepine receptor response to stress in rats. Hormones and Behavior 1993;27:348-365.

o Drugan RC. Peripheral benzodiazepine receptors: molecular pharmacology to possible physiological significance in stress-induced hypertension. Clinical Neuropharmacology 1996;19:475-496.

o DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition), 1994

o DSM-IV-TR(Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition - text revision), 2000

o Ducis I, Norenberg LO, Norenberg MD. The benzodiazepine receptor in cultured astrocytes from genetically epilepsy-prone rats. Brain Res. 1990;531(1-2):318- 21.

o Duman RS, Malberg J, Nakagawa S. Regulation of adult neurogenesis by psychotropic drugs and stress. J Pharmacol Exp Ther. 2001;299(2):401-7.

Review.

o Duman RS, Nakagawa S, Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology. 2001;25(6):836-44.

Review.

o Ebner MJ, Corol DI, Havlíková H, Honour JW, Fry JP. Identification of neuroactive steroids and their precursors and metabolites in adult male rat brain.

Endocrinology. 2006;147(1):179-90.

(8)

o Eshleman AJ, Murray TF. Differential binding properties of the peripheral-type benzodiazepine ligands [3H]PK 11195 and [3H]Ro 5-4864 in trout and mouse brain membranes. J Neurochem. 1989 Aug;53(2):494-502.

o Everson MP, Kotler S, Blackburn WD Jr. Stress and immune dysfunction in Gulf War veterans. Ann N Y Acad Sci. 1999;876:413-8. Review.

o Fagiolini A, Kupfer DJ, Masalehdan A, Scott JA, Houck PR, Frank E. Functional impairment in the remission phase of bipolar disorder. Bipolar Disord.

2005;7(3):281-5.

o Fares F, Weizman A, Zlotogorski D, Gavish M. Ontogenetic development of peripheral benzodiazepine binding sites in rat brain, heart and lung. Brain Res.

1987;408(1-2):381-4.

o Ferrari E, Cravello L, Falvo F, Barili L, Solerte SB, Fioravanti M, Magri F.

Neuroendocrine features in extreme longevity. Exp Gerontol. 2008;43(2):88-94.

o Ferrari E, Mirani M, Barili L, Falvo F, Solerte SB, Cravello L, Pini L, Magri F.

Cognitive and affective disorders in the elderly: a neuroendocrine study. Arch Gerontol Geriatr Suppl. 2004;(9):171-82.

o Ferrero P, Rocca P, Benna P, De Leo C, Montalenti E, Ravizza L, Bergamasco B.

An analysis of peripheral type benzodiazepine receptors on blood mononuclear cells during high dose steroid treatment of multiple sclerosis. Ital J Neurol Sci.

1992;13(8):685-91.

o First, M.B., Spitzer, R.L., Williams, J.B.W., Gibbon, M., 1995. Structured Clinical Interview for DSM-IV-Patient Edition (SCID-P). American Psychiatric Press, Washington, DC.

o Föcking M, Hölker I, Trapp T. Chronic glucocorticoid receptor activation impairs CREB transcriptional activity in clonal neurons. Biochem Biophys Res Commun. 2003;304(4):720-3.

o Frye CA, Reed TA. Androgenic neurosteroids: anti-seizure effects in an animal model of epilepsy. Psychoneuroendocrinology. 1998;23(4):385-99.

o Galiègue S, Jbilo O, Combes T, Bribes E, Carayon P, Le Fur G, Casellas P.

Cloning and characterization of PRAX-1. A new protein that specifically interacts with the peripheral benzodiazepine receptor. J Biol Chem.

1999;274(5):2938-52.

o Garnier M, Boujrad N, Ogwuegbu SO, Hudson JR Jr, Papadopoulos V. The polypeptide diazepam-binding inhibitor and a higher affinity mitochondrial peripheral-type benzodiazepine receptor sustain constitutive steroidogenesis in the R2C Leydig tumor cell line. J Biol Chem. 1994;269(35):22105-12.

o Gavish M, Bachman I, Shoukrun R, Katz Y, Veenman L, Weisinger G, Weizman A. Enigma of the peripheral benzodiazepine receptor. Pharmacological Reviews 1999;51:629-650.

o Gavish M, Laor N, Bidder M, Fisher D, Fonia O, Muller U, Reiss A, Wolmer L, Karp L, Weizman R. Altered platelet peripheral-type benzodiazepine receptor in posttraumatic stress disorder. Neuropsycopharmacology 1996;14:181-186.

o Gavish M, Bachman I, Shoukrun R, Katz Y, Veenman L, Weisinger G, Weizman A. Enigma of the peripheral benzodiazepine receptor. Pharmacological Reviews 1999;51:629-650.

o Gelernter J, Southwick S, Goodson S, Morgan A, Nagy L, Charney DS. No association between D2 dopamine receptor (DRD2) "A" system alleles, or DRD2 haplotypes, and posttraumatic stress disorder. Biol Psychiatry. 1999;45(5):620-5.

o Geracioti TD Jr, West SA, Baker DG, Hill KK, Ekhator NN, Wortman MD, Keck

PE Jr, Norman AB. Low CSF concentration of a dopamine metabolite in tobacco

smokers. Am J Psychiatry. 1999;156(1):130-2.

(9)

o Gilbertson MW, Williston SK, Paulus LA, Lasko NB, Gurvits TV, Shenton ME, Pitman RK, Orr SP. Configural cue performance in identical twins discordant for posttraumatic stress disorder: theoretical implications for the role of hippocampal function. Biol Psychiatry. 2007;62(5):513-20.

o Gildersleeve DL, Van Dort ME, Johnson JW, Sherman PS, Wieland DM.

Synthesis and evaluation of [123I]-iodo-PK11195 for mapping peripheral-type benzodiazepine receptors (omega 3) in heart. Nucl Med Biol. 1996;23(1):23-8.

o Golani I, Weizman A, Leschiner S, Spanier I, Eckstein N, Limor R, Yanai J, Maaser K, Scherübl H, Weisinger G, Gavish M. Hormonal regulation of peripheral benzodiazepine receptor binding properties is mediated by subunit interaction. Biochemistry. 2001;40(34):10213-22.

o Goldman-Rakic PS, Muly EC 3rd, Williams GV. D(1) receptors in prefrontal cells and circuits. Brain Res Brain Res Rev. 2000;31(2-3):295-301.

o Gunnar M, Quevedo K. The neurobiology of stress and development. Annu Rev Psychol. 2007;58:145-73.

o Hagiwara M, Brindle P, Harootunian A, Armstrong R, Rivier J, Vale W, Tsien R, Montminy MR. Coupling of hormonal stimulation and transcription via the cyclic AMP-responsive factor CREB is rate limited by nuclear entry of protein kinase A. Mol Cell Biol. 1993;13(8):4852-9.

o Hashimoto K, Inoue O, Suzuki K, Yamasaki T, Kojima M. Synthesis and evaluation of 11C-PK 11195 for in vivo study of peripheral-type benzodiazepine receptors using positron emission tomography.Ann Nucl Med. 1989;3(2):63-71.

o Hayley S, Poulter MO, Merali Z, Anisman H. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity.

Neuroscience. 2005;135(3):659-78. Review.

o Hechter O, Grossman A, Chatterton RT Jr. Relationship of dehydroepiandrosterone and cortisol in disease. Med Hypotheses. 1997;49(1):85- 91.

o Horowitz MJ, Wilner N, Kaltreider N, Alvarez W. Signs and symptoms of posttraumatic stress disorder. Arch Gen Psychiatry. 1980;37(1):85-92.

o Horowitz, M., Wilner, N., Alvarez, W., 1979. Impact of Event Scale: a measure of subjective stress. Psychosomatic Medicine 41, 209-218.

o Hurn PD and Macrae IM. Estrogen as a Neuroprotectant in Stroke. Journal of Cerebral Blood Flow & Metabolism 2000;20:631–652.

o Jansen LM, Gispen-de Wied CC, Gademan PJ, De Jonge RC, van der Linden JA, Kahn RS. Blunted cortisol response to a psychosocial stressor in schizophrenia.

Schizophr Res. 1998;33(1-2):87-94.

o Joëls M, de Kloet ER. Effects of glucocorticoids and norepinephrine on the excitability in the hippocampus. Science. 1989;245(4925):1502-5.

o Joëls M, Karst H, Krugers HJ, Lucassen PJ. Chronic stress: implications for neuronal morphology, function and neurogenesis.Front Neuroendocrinol.

2007;28(2-3):72-96.Review.

o Johnson MR, Marazziti D, Brawman-Mintzer O, Emmanuel NP, Ware MR, Morton WA, Rossi A, Cassano GB, Lydiard RB. Abnormal peripheral benzodiazepine receptor density associated with generalized social phobia. Biol Psychiatry. 1998;43(4):306-9.

o Jordà EG, Jiménez A, Verdaguer E, Canudas AM, Folch J, Sureda FX, Camins A, Pallàs M. Evidence in favour of a role for peripheral-type benzodiazepine receptor ligands in amplification of neuronal apoptosis. Apoptosis.

2005;10(1):91-104.

(10)

o Josselyn SA, Shi C, Carlezon WA Jr, Neve RL, Nestler EJ, Davis M. Long-term memory is facilitated by cAMP response element-binding protein overexpression in the amygdala. J Neurosci. 2001;21(7):2404-12.

o Kaang BK, Kandel ER, Grant SG. Activation of cAMP-responsive genes by stimuli that produce long-term facilitation in Aplysia sensory neurons. Neuron.

1993;10(3):427-35.

o Kagan BL, Leskin G, Haas B, Wilkins J, Foy D. Elevated lipid levels in Vietnam veterans with chronic posttraumatic stress disorder. Biol Psychiatry.

1999;45(3):374-7.

o Kangas M, Henry JL, Bryant RA. Posttraumatic stress disorder following cancer.

A conceptual and empirical review. Clin Psychol Rev. 2002;22(4):499-524.

o Karp L, Weizman A, Fliman M, Tyano S, Gavish M. Peripheral benzodiazepine receptors on platelets in chronic and detoxified alcoholics. Neuropharmacology.

1991;30(6):665-9.

o Karp L, Weizman A, Tyano S, Gavish M. Examination stress, platelet peripheral benzodiazepine binding sites, and plasma hormone levels. Life Sci.

1989;44(16):1077-82.

o Kennedy CH and Zillmer E. Military Psychology: Clinical and Operational Applications, Guilford Press (2006)

o Kessler R, Sonnega A, Bromet E. Post-traumatic Stress Disorder in the National Comorbidity Survey. Archives of General Psychiatry 1995;52:1048-1060.

o Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Archives of General Psychiatry, 2005;62(6):617- 27.

o Koch JM, Kell S, Hinze-Selch D, Aldenhoff JB. Changes in CREB- phosphorylation during recovery from major depression. J Psychiatr Res.

2002;36(6):369-75.

o Krugers HJ, Maslam S, Van Vuuren SM, Korf J, Joëls M. Postischemic steroid modulation: effects on hippocampal neuronal integrity and synaptic plasticity.

Cereb Blood Flow Metab. 1999;19(10):1072-82.

o Kunduzova OR, Escourrou G, De La Farge F, Salvayre R, Séguélas MH, Leducq N, Bono F, Herbert JM, Parini A. Involvement of peripheral benzodiazepine receptor in the oxidative stress, death-signaling pathways, and renal injury induced by ischemia-reperfusion. J Am Soc Nephrol. 2004;15(8):2152-60.

o Kupfer DJ. Dimensional models for research and diagnosis: a current dilemma.

Journal of Abnormal Psychology 2005;114:557-559.

o Kwok RP, Lundblad JR, Chrivia JC, Richards JP, Bächinger HP, Brennan RG, Roberts SG, Green MR, Goodman RH. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature. 1994;370(6486):223-6.

o Lacapère JJ, Papadopoulos V. Peripheral-type benzodiazepine receptor: structure and function of a cholesterol-binding protein in steroid and bile acid biosynthesis. Steroids. 2003;68(7-8):569-85. Review.

o Lapchak PA, Araujo DM. Preclinical development of neurosteroids as neuroprotective agents for thetreatment of neurodegenerative diseases. Int Rev Neurobiol. 2001;46:379-97. Review.

o Le Fur G, Guilloux F, Rufat P, Benavides J, Uzan A, Renault C, Dubroeucq MC,

Guérémy C. Peripheral benzodiazepine binding sites: effect of PK 11195,1-(2-

chlorophenyl)-N-methyl-(1-methylpropyl)-3 isoquinolinecarboxamide. II. In

vivo studies. Life Sci. 1983 Apr 18;32(16):1849-56.

(11)

o Le Fur G, Perrier ML, Vaucher N, Imbault F, Flamier A, Benavides J, Uzan A, Renault C, Dubroeucq MC, Guérémy C. Peripheral benzodiazepine binding sites:

effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3- isoquinolinecarboxamide. I. In vitro studies. Life Sci. 1983 Apr 18;32(16):1839- 47.

o LeDoux J.E. Synaptic self. New York: Viking. 2001.

o Lee EH, Lee CP, Wang HI, Lin WR. Hippocampal CRF, NE, and NMDA system interactions in memory processing in the rat. Synapse. 1993;14(2):144-53.

o Legradi G, Holzer D, Kapcala LP, Lechan RM. Glucocorticoids.

Neuroendocrinology. 1997;66:86–97.

o Lemieux AM, Coe CL. Abuse-related posttraumatic stress disorder: evidence for chronic neuroendocrine activation in women. Psychosom Med. 1995;57(2):105- 15.

o Lesouhaitier O, Feuilloley M, Lihrmann I, Ugo I, Fasolo A, Tonon MC, Vaudry H.Localization of diazepam-binding inhibitor-related peptides and peripheral type benzodiazepine receptors in the frog adrenal gland. Cell Tissue Res.

1996;283(3):403-12.

o Li H, Degenhardt B, Tobin D, Yao ZX, Tasken K, Papadopoulos V.

Identification, localization, and function in steroidogenesis of PAP7: a peripheral-type benzodiazepine receptor- and PKA (RIalpha)-associated protein.

Mol Endocrinol. 2001;15(12):2211-28.

o Lindley SE, Carlson EB, Benoit M. Basal and dexamethasone suppressed salivary cortisol concentrations in a community sample of patients with posttraumatic stress disorder.Biol Psychiatry. 2004;55(9):940-5.

o Liu J, Li H, Papadopoulos V. PAP7, a PBR/PKA-RIalpha-associated protein: a new element in the relay of the hormonal induction of steroidogenesis. J Steroid Biochem Mol Biol. 2003;85(2-5):275-83. Review.

o Lonze BE and Ginty DD. Function and regulation of CREB family transcription factors in the nervous system. Neuron 2002;35:605– 623.

o Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. The Journal of Biological Chemistry 1951:193;265-267.

o Maaser K, Höpfner M, Jansen A, Weisinger G, Gavish M, Kozikowski AP, Weizman A, Carayon P, Riecken EO, Zeitz M, Scherübl H. Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human colorectal cancer cells. Br J Cancer. 2001;85(11):1771-80.

o Macario AJ, de Macario EC. The pathology of cellular anti-stress mechanisms: a new frontier. Stress. 2004;7(4):243-9. Review.

o Macleod MR, Johansson IM, Söderström I, Lai M, Gidö G, Wieloch T, Seckl JR, Olsson T. Mineralocorticoid receptor expression and increased survival following neuronal injury. Eur J Neurosci. 2003;17(8):1549-55.

o Maes M, Lin AH, Verkerk R, Delmeire L, Van Gastel A, Van der Planken M, Scharpé S. Serotonergic and noradrenergic markers of post-traumatic stress disorder with and without major depression. Neuropsychopharmacology.

1999;20(2):188-97.

o Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry. 1995;19(1):11-38.

Review.

o Maj M. The Aftermath of the Concept of “Psychiatric Comorbidity”.

Psychotherapy and Psychosomatics 2005;74:67-68.

(12)

o Majewska MD, Demirgören S, Spivak CE, London ED. The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor. Brain Res. 1990;526(1):143-6.

o Majewska MD. Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog Neurobiol.

1992;38(4):379-95. Review.

o Makara GB, Haller J. Non-genomic effects of glucocorticoids in the neural system. Evidence, mechanisms and implications. Prog Neurobiol.

2001;65(4):367-90. Review.

o Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM. The nuclear receptor superfamily: the second decade. Cell. 1995;83(6):835-9. Review.

o Marazziti D, Rotondo A, Martini C, Giannaccini G, Lucacchini A, Pancioli- Guadagnucci ML, Diamond BI, Borison R, Cassano GB. Changes in peripheral benzodiazepine receptors in patients with panic disorder and obsessive- compulsive disorder. Neuropsychobiology. 1994;29(1):8-11.

o Margolin G, Gordis EB. The effects of family and community violence on children. Annual Review of Psychology, 2000; 51: 445-79.

o Marx CE, Jarskog LF, Lauder JM, Gilmore JH, Lieberman JA, Morrow AL.

Neurosteroid modulation of embryonic neuronal survival in vitro following anoxia. Brain Res. 2000 Jul 14;871(1):104-12.

o Maser JD, Akiskal HS. Spectrum concepts in major mental disorders. The Psychiatric Clinics of North America 2002;25:XI-XIII.

o McEnery MW. The mitochondrial benzodiazepine receptor: evidence for association with the voltage-dependent anion channel (VDAC). J Bioenerg Biomembr. 1992;24(1):63-9. Review.

o McEwen BS, Weiss JM, Schwartz LS. Selective retention of corticosterone by limbic structures in rat brain. Nature. 1968;220(5170):911-2.

o McEwen BS, Weiss JM, Schwartz LS. Uptake of corticosterone by rat brain and its concentration by certain limbic structures. Brain Res. 1969;16(1):227-41.

o McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev. 2007;87(3):873-904. Review.

o McFarlane AC, Atchison M, Yehuda R. The acute stress response following motor vehicle accidents and its relation to PTSD. Ann N Y Acad Sci.

1997;821:437-41.

o McGaugh JL. Preserving the presence of the past. Hormonal influences on memory storage. Am Psychol. 1983;38(2):161-74.

o McNally RJ, Bryant RA, Ehlers A. Does early psychological intervention promote recovery from posttraumatic stress? Psychological Science in the Public Interest. 2003;4:45–79.

o Meijer OC, Kortekaas R, Oitzl MS, de Kloet ER. Acute rise in corticosterone facilitates 5-HT(1A) receptor-mediated behavioural responses. Eur J Pharmacol.

1998;351(1):7-14.

o Mellon SH, Griffin LD. Synthesis, regulation, and function of neurosteroids.

Endocr Res. 2002;28(4):463.

o Mendelson WB, Martin JV, Perlis M, Wagner R, Majewska MD, Paul SM. Sleep induction by an adrenal steroid in the rat. Psychopharmacology (Berl).

1987;93(2):226-9.

o Miró O, Alonso JR, Jarreta D, Casademont J, Urbano-Márquez A, Cardellach F.

Smoking disturbs mitochondrial respiratory chain function and enhances lipid

(13)

peroxidation on human circulating lymphocytes. Carcinogenesis 1999;20;1331- 1336.

o Montminy MR, Sevarino KA, Wagner JA, Mandel G, Goodman RH.

Identification of a cyclic-AMP-responsive element within the rat somatostatin gene. Proc Natl Acad Sci U S A. 1986;83(18):6682-6.

o Morgan CA 3rd, Grillon C, Lubin H, Southwick SM. Startle deficits in women with sexual assault-related PTSD. Ann N Y Acad Sci. 1997;821:486-90.

o Morgan CA 3rd, Grillon C, Lubin H, Southwick SM. Startle reflex abnormalities in women with sexual assault-related posttraumatic stress disorder. Am J Psychiatry. 1997;154(8):1076-80.

o Morrow AL, Porcu P, Boyd KN, Grant KA. Hypothalamic-pituitary-adrenal axis modulation of GABAergic neuroactive steroids influences ethanol sensitivity and drinking behavior. Dialogues Clin Neurosci. 2006;8(4):463-77. Review.

o Morrow AL, Suzdak PD, Paul SM. Steroid hormone metabolites potentiate GABA receptor-mediated chloride ion flux with nanomolar potency. Eur J Pharmacol. 1987;142(3):483-5.

o Mueser KT, Goodman LB, Trumbetta SL, Rosenberg SD, Osher C, Vidaver R, Auciello P, Foy DW. Trauma and posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology 1998;66:493-499.

o Munck A, Guyre PM, Holbrook NJ. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev. 1984;5(1):25- 44. Review.

o Murialdo G, Nobili F, Rollero A, Gianelli MV, Copello F, Rodriguez G, Polleri A.

Hippocampal perfusion and pituitary-adrenal axis in Alzheimer's disease.

Neuropsychobiology. 2000;42(2):51-7.

o Nakamura K, Fukunishi I, Nakamoto Y, Iwahashi K, Yoshii M. Peripheral-type benzodiazepine receptors on platelets are correlated with the degrees of anxiety in normal human subjects. Psychopharmacology (Berl). 2002;162(3):301-3.

o Nemeroff CB, Bremner JD, Foa EB, Mayberg HS, North CS, Stein MB.

Posttraumatic stress disorder: a state-of-the-science review. Journal of Psychiatry Research 2006;40:1-21.

o Neria Y, Bromet EJ, Sievers S, Lavelle J, Fochtmann LJ. Trauma exposure and posttraumatic stress disorder in psychosis: findings from a first-admission cohort.

Journal of Consulting and Clinical Psychology 2002;70:246-251.

o Nestler EJ, Terwilliger RZ, Duman RS. Chronic antidepressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex. J Neurochem 1989;53: 1644–1647.

o Newport DJ and Nemeroff CB, Neurobiology of posttraumatic stress disorder.

Current Opinion in Neurobiology 2000;10:211–218.

o Nudmamud S, Siripurkpong P, Chindaduangratana C, Harnyuttanakorn P, Lotrakul P, Laarbboonsarp W, Srikiatkhachorn A, Kotchabhakdi N, Casalotti SO.

Stress, anxiety and peripheral benzodiazepine receptor mRNA levels in human lymphocytes. Life Sciences 2000;67:2221-2231.

o Okuda S, Roozendaal B, McGaugh JL. Glucocorticoid effects on object recognition memory require training-associated emotional arousal. Proc Natl Acad Sci U S A. 2004;101(3):853-8.

o Olff M, de Vries GJ, Güzelcan Y, Assies J, Gersons BP. Changes in cortisol and DHEA plasma levels after psychotherapy for PTSD. Psychoneuroendocrinology.

2007;32(6):619-26.

o Otto MW, Perlman CA, Wernicke R, Reese HE, Bauer MS, Pollack MH.

Posttraumatic stress disorder in patients with bipolar disorder: a review of

(14)

prevalence, correlates, and treatment strategies. Bipolar Disorder 2004;6:470- 479.

o Papadopoulos V, Dharmarajan AM, Li H, Culty M, Lemay M, Sridaran R.

Mitochondrial peripheral-type benzodiazepine receptor expression. Correlation with gonadotropin-releasing hormone (GnRH) agonist-induced apoptosis in the corpus luteum. Biochem Pharmacol. 1999;58(9):1389-93.

o Papadopoulos, V., Baraldi, M., Guilarte, T.R., Knudsen, T.B., Lacapere, J.J., Lindemann, P., Norenberg, M.D., Nutt, D., Weizman, A., Zhang, M., Gavish, M., 2006. Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends in Pharmacological Sciences 27,: 402-409.

o Paul SM, Purdy RH. Neuroactive steroids. FASEB J. 1992;6(6):2311-22.

Review.

o Pavić L, Gregurek R, Rados M, Brkljacić B, Brajković L, Simetin-Pavić I, Ivanac G, Pavlisa G, Kalousek V. Smaller right hippocampus in war veterans with posttraumatic stress disorder. Psychiatry Res. 2007;154(2):191-8.

o Peterson CL, Duerson KC, Buckley AR, Putnam CW, Russell DH, Laird HE 2nd.

Embryological development of peripheral benzodiazepine binding sites in the chick liver. Proc West Pharmacol Soc. 1988;31:263-4.

o Piazza PV, Maccari S, Deminière JM, Le Moal M, Mormède P, Simon H.

Corticosterone levels determine individual vulnerability to amphetamineself- administration.Proc Natl Acad Sci U S A. 1991;88(6):2088-92.

o Pico-Alfonso MA, Garcia-Linares MI, Celda-Navarro N, Herbert J, Martinez M.

Changes in cortisol and dehydroepiandrosterone in women victims of physical and psychological intimate partner violence. Biol Psychiatry. 2004;56(4):233-40.

o Pini S, Abelli M, Mauri M, Muti M, Iazzetta P, Banti S, Cassano GB. Clinical correlates and significance of separation anxiety in patients with bipolar disorder.

Bipolar Disord. 2005;7(4):370-6.

o Pitman RK, Gilbertson MW, Gurvits TV, May FS, Lasko NB, Metzger LJ, Shenton ME, Yehuda R, Orr SP; Harvard/VA PTSD Twin Study Investigators.

Clarifying the origin of biological abnormalities in PTSD through the study of identical twins discordant for combat exposure. Ann N Y Acad Sci.

2006;1071:242-54.

o Pitman RK, Orr SP. Twenty-four hour urinary cortisol and catecholamine excretion in combat-related posttraumatic stress disorder. Biol Psychiatry.

1990;27(2):245-7.

o Pollack MH, Simon NM, Fagiolini A, Pitman R, McNally RJ, Nierenberg AA, Miyahara S, Sachs GS, Perlman C, Ghaemi SN, Thase ME, Otto MW. Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorder. Journal of Clinical Psychiatry 2006;67:394-399.

o Psarra AM, Solakidi S, Sekeris CE. The mitochondrion as a primary site of action of regulatory agents involved in neuroimmunomodulation. Ann N Y Acad Sci. 2006;1088:12-22. Review.

o Ramos BP, Birnbaum SG, Lindenmayer I, Newton SS, Duman RS, Arnsten AF.

Dysregulation of protein kinase a signaling in the aged prefrontal cortex: new strategy for treating age-related cognitive decline. Neuron. 2003;40(4):835-45.

o Rangarajan PN, Umesono K, Evans RM. Modulation of glucocorticoid receptor function by protein kinase A. Mol Endocrinol. 1992;6(9):1451-7.

o Rasmusson AM, Vasek J, Lipschitz DS, Vojvoda D, Mustone ME, Shi Q,

Gudmundsen G, Morgan CA, Wolfe J, Charney DS. An increased capacity for

adrenal DHEA release is associated with decreased avoidance and negative mood

(15)

symptoms in women with PTSD. Neuropsychopharmacology. 2004;29(8):1546- 57.

o Rasmusson AM, Vythilingam M, Morgan CA 3rd. The neuroendocrinology of posttraumatic stress disorder: new directions. CNS Spectr. 2003;8(9):651-6, 665- 7. Review.

o Resnick HS, Yehuda R, Pitman RK, Foy DW. Effect of previous trauma on acute plasma cortisol level following rape. Am J Psychiatry. 1995;152(11):1675-7.

o Riad-Fahmy D, Read GF, Walker RF, Griffiths K. Steroids in saliva for assessing endocrine function. Endocr Rev. 1982;3(4):367-95. Review.

o Ritsner M, Maayan R, Gibel A, Strous RD, Modai I, Weizman A.Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients. Eur Neuropsychopharmacol. 2004;14(4):267-73.

o Ritsner M, Modai I, Gibel A, Leschiner S, Silver H, Tsinovoy G, Weizman A, Gavish M. Decreased platelet peripheral-type benzodiazepine receptors in persistently violent schizophrenia patients. J Psychiatr Res. 2003;37(6):549-56.

o Robel P, Baulieu EE. Neurosteroids: biosynthesis and function. Crit Rev Neurobiol. 1995;9(4):383-94. Review.

o Roberts E, Bologa L, Flood JF, Smith GE. Effects of dehydroepiandrosterone and its sulfate on brain tissue in culture and on memory in mice. Brain Res.

1987;406(1-2):357-62.

o Rocca P, Beoni AM, Eva C, Ferrero P, Maina G, Bogetto F, Ravizza L.

Lymphocyte peripheral benzodiazepine receptor mRNA decreases in obsessive- compulsive disorder. Eur Neuropsychopharmacol. 2000;10(5):337-40.

o Rocca P, Beoni AM, Eva C, Ferrero P, Zanalda E, Ravizza L. Peripheral benzodiazepine receptor messenger RNA is decreased in lymphocytes of generalized anxiety disorder patients. Biol Psychiatry. 1998;43(10):767-73.

o Rocca P, Ferrero P, Gualerzi A, Zanalda E, Maina G, Bergamasco B, Ravizza L.

Peripheral-type benzodiazepine receptors in anxiety disorders. Acta Psychiatr Scand. 1991;84(6):537-44.

o Rohleder N, Joksimovic L, Wolf JM, Kirschbaum C. Hypocortisolism and increased glucocorticoid sensitivity of pro-Inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder. Biol Psychiatry.

2004;55(7):745-51.

o Rohleder N, Karl A. Role of endocrine and inflammatory alterations in comorbid somatic diseases of post-traumatic stress disorder. Minerva Endocrinol.

2006;31(4):273-88. Review.

o Roozendaal B, Koolhaas JM, Bohus B. The central amygdala is involved in conditioning but not in retention of active and passive shock avoidance in male rats. Behav Neural Biol. 1993;59(2):143-9.

o Roozendaal B, McReynolds JR, McGaugh JL. The basolateral amygdala interacts with the medial prefrontal cortex in regulating glucocorticoid effects on working memory impairment. J Neurosci. 2004;24(6):1385-92.

o Rupprecht R, di Michele F, Hermann B, Ströhle A, Lancel M, Romeo E, Holsboer F. Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology. Brain Res Brain Res Rev.

2001;37(1-3):59-67. Review.

o Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O, Belzung C, Hen R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science.

2003;301(5634):805-9.

(16)

o Scherrer JF, Xian H, Kapp JM, Waterman B, Shah KR, Volberg R, Eisen SA.

Association between exposure to childhood and lifetime traumatic events and lifetime pathological gambling in a twin cohort. J Nerv Ment Dis.

2007;195(1):72-8.

o Schnurr PP, Rosenberg SD, Friedman MJ. Change in MMPI scores from college to adulthood as a function of military service. Journal of Abnormal Psychology 1993;102:288-296.

o Schoemaker H, Smith TL, Yamamura HI. Effect of chronic ethanol consumption on central and peripheral type benzodiazepine binding sites in the mouse brain.

Brain Res. 1983;258(2):347-50.

o Schumacher M, Akwa Y, Guennoun R, Robert F, Labombarda F, Desarnaud F, Robel P, De Nicola AF, Baulieu EE. Steroid synthesis and metabolism in the nervous system: trophic and protective effects. J Neurocytol. 2000;29(5-6):307- 26. Review.

o Seasholtz AF, Thompson RC, Douglass JO. Identification of a cyclic adenosine monophosphate-responsive element in the rat corticotropin-releasing hormone gene, Mol. Endocrinol. 1988;2:1311–1319.

o Seckl JR, Walker BR. Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action. Endocrinology.

2001;142(4):1371-6. Review.

o Selye H. The evolution of the stress concept. Am Sci. 1973;61(6):692-9.

o Shalev AY, Freedman S, Peri T, Brandes D, Sahar T, Orr SP, Pitman RK.

Prospective study of posttraumatic stress disorder and depression following trauma. Am J Psychiatry. 1998;155(5):630-7.

o Shalev AY, Sahar T, Freedman S, Peri T, Glick N, Brandes D, Orr SP, Pitman RK. A prospective study of heart rate response following trauma and the subsequent development of posttraumatic stress disorder. Arch Gen Psychiatry.

1998;55(6):553-9.

o Shaywitz A and Greenberg ME. CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu. Rev. Biochem.

1999;68:821–861.

o Shin LM, Rauch SL, Pitman RK. Amygdala, medial prefrontal cortex, and hippocampal function in PTSD. Ann N Y Acad Sci. 2006;1071:67-79. Review.

o Smith MY, Redd WH, Peyser C, Vogl D. Post-traumatic stress disorder in cancer:

a review. Psychooncology. 1999;8(6):521-37.

o Smith SM, Vale WW. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci. 2006;8(4):383-95.

Review.

o Snyder MJ, Van Antwerpen R. Evidence for a diazepam-binding inhibitor (DBI) benzodiazepine receptor-like mechanism in ecdysteroidogenesis by the insect prothoracic gland. Cell Tissue Res. 1998;294(1):161-8.

o Söndergaard HP, Hansson LO, Theorell T. Elevated blood levels of dehydroepiandrosterone sulphate vary with symptom load in posttraumatic stress disorder: findings from a longitudinal study of refugees in Sweden. Psychother Psychosom. 2002;71(5):298-303.

o Soreni N, Apter A, Weizman A, Don-Tufeled O, Leschiner S, Karp L, Gavish M.

Decreased platelet peripheral-type benzodiazepine receptors in adolescent inpatients with repeated suicide attempts. Biol Psychiatry. 1999;46(4):484-8.

o Southwick SM, Morgan CA 3rd, Charney DS, High JR. Yohimbine use in a natural setting: effects on posttraumatic stress disorder.Biol Psychiatry.

1999;46(3):442-4.

(17)

o Spivak B, Maayan R, Kotler M, Mester R, Gil-Ad I, Shtaif B, Weizman A.

Elevated circulatory level of GABA(A)--antagonistic neurosteroids in patients with combat-related post-traumatic stress disorder. Psychol Med.

2000;30(5):1227-31.

o Spivak B, Vered Y, Graff E, Blum I, Mester R, Weizman A.Low platelet-poor plasma concentrations of serotonin in patients with combat-related posttraumatic stress disorder. Biol Psychiatry. 1999;45(7):840-5.

o Starkman MN, Schteingart DE. Neuropsychiatric manifestations of patients with Cushing's syndrome. Relationship to cortisol and adrenocorticotropic hormone levels. Arch Intern Med. 1981;141(2):215-9.

o Stein MB, Kerridge C, Dimsdale JE, Hoyt DB. Pharmacotherapy to prevent PTSD: Results from a randomized controlled proof-of-concept trial in physically injured patients.J Trauma Stress. 2007;20(6):923-32.

o Strous RD, Maayan R, Lapidus R, Stryjer R, Lustig M, Kotler M, Weizman A.

Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Arch Gen Psychiatry.

2003;60(2):133-41.

o Syapin PJ, Skolnick P. Characterization of benzodiazepine binding sites in cultured cells of neural origin. J Neurochem. 1979;32(3):1047-51.

o Tait GR, McManus K, Bellavance F, Lara N, Chrapko W, Le Mellédo JM.

Neuroactive steroid changes in response to challenge with the panicogenic agent pentagastrin. Psychoneuroendocrinology. 2002;27(4):417-29.

o Thomas G, Frenoy N, Legrain S, Sebag-Lanoe R, Baulieu EE, Debuire B. Serum dehydroepiandrosterone sulfate levels as an individual marker. Clin Endocrinol Metab. 1994;79(5):1273-6.

o Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 2002;53(4):865-71.

o Tsujimoto Y, Shimizu S. VDAC regulation by the Bcl-2 family of proteins. Cell Death Differ. 2000;7(12):1174-81. Review.

o Tucker P, Ruwe WD, Masters B, Parker DE, Hossain A, Trautman RP, Wyatt DB.

Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder. Biol Psychiatry.

2004;56(2):121-8.

o Tully T, Bourtchouladze R, Scott R, Tallman J. Targeting the CREB pathway for memory enhancers.Nat Rev Drug Discov. 2003;2(4):267-77. Review.

o van Broekhoven F, Verkes RJ. Neurosteroids in depression: a review.

Psychopharmacology (Berl). 2003;165(2):97-110. Review.

o van Kammen DP, Guidotti A, Kelley ME, Gurklis J, Guarneri P, Gilbertson MW, Yao JK, Peters J, Costa E. CSF diazepam binding inhibitor and schizophrenia:

clinical and biochemical relationships. Biol Psychiatry. 1993;34(8):515-22.

o Vanover KE, Rosenzweig-Lipson S, Hawkinson JE, Lan NC, Belluzzi JD, Stein L, Barrett JE, Wood PL, Carter RB. Characterization of the anxiolytic properties of a novel neuroactive steroid, Co 2-6749 (GMA-839; WAY-141839; 3alpha,21- dihydroxy-3beta-trifluoromethyl-19-nor-5beta-pregnan-20-one), a selective modulator of gamma-aminobutyric acid(A) receptors.J Pharmacol Exp Ther.

2000;295(1):337-45.

o Veenman L, Gavish M. The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development. Pharmacol Ther.

2006;110(3):503-24. Review.

o Veenman L, Leschiner S, Spanier I, Weisinger G, Weizman A, Gavish M. PK

11195 attenuates kainic acid-induced seizures and alterations in peripheral-type

(18)

benzodiazepine receptor (PBR) protein components in the rat brain. J Neurochem. 2002;80(5):917-27.

o Venero C, Borrell J. Rapid glucocorticoid effects on excitatory amino acid levels in the hippocampus: a microdialysis study in freely moving rats. Eur J Neurosci.

1999;11(7):2465-73.

o Verma A, Snyder SH. Peripheral type benzodiazepine receptors. Annu Rev Pharmacol Toxicol. 1989;29:307-22. Review.

o Verma IM, Sassone-Corsi P. Proto-oncogene fos: complex but versatile regulation. Cell. 1987;51(4):513-4.

o Vermetten E, Bremner JD. Circuits and systems in stress. I. Preclinical studies.

Depress Anxiety. 2002;15(3):126-47. Review.

o Vermetten E, Bremner JD. Circuits and systems in stress. II. Applications to neurobiology and treatment in posttraumatic stress disorder. Depress Anxiety.

2002;16(1):14-38. Review.

o Verrier F, Mignotte B, Jan G, Brenner C. Study of PTPC composition during apoptosis for identification of viral protein target. Ann N Y Acad Sci.

2003;1010:126-42.

o Versijpt J, Dumont F, Thierens H, Jansen H, De Vos F, Slegers G, Santens P, Dierckx RA, Korf J. Biodistribution and dosimetry of [123I]iodo-PK 11195: a potential agent for SPET imaging of the peripheral benzodiazepine receptor. Eur J Nucl Med. 2000;27(9):1326-33.

o Warner M, Gustafsson JA. Cytochrome P450 in the brain: neuroendocrine functions. Front Neuroendocrinol. 1995;16(3):224-36. Review.

o Watson S, Gallagher P, Ritchie JC, Ferrier IN, Young AH. Hypothalamic- pituitary-adrenal axis function in patients with bipolar disorder. Br J Psychiatry.

2004;184:496-502.

o Weizman A, Amiri Z, Katz Y, Snyder SH, Gavish M. Testosterone prevents castration-induced reduction in peripheral benzodiazepine receptors in Cowper's gland and adrenal. Brain Res. 1992;572(1-2):72-5.

o Weizman A, Burgin R, Harel Y, Karp L, Gavish M. Platelet peripheral-type benzodiazepine receptor in major depression. J Affect Disord. 1995;33(4):257- 61.

o Weizman R, Gavish M. Molecular cellular and behavioral aspects of peripheral- type benzodiazepine receptors. Clinical Neuropharmacology 1993;16:401-417.

o Weizman R, Laor N, Karp L, Dagan E, Reiss A, Dar DE, Wolmer L, Gavish M.

Alteration of platelet benzodiazepine receptors by stress of war. Am J Psychiatry.

1994;151(5):766-7.

o Westermann J, Demir A, Herbst V. Determination of cortisol in saliva and serum by a luminescence-enhanced enzyme immunoassay. Clin Lab. 2004;50(1-2):11- 24.

o Wilson SN, van der Kolk B, Burbridge J, Fisler R, Kradin R. Phenotype of blood lymphocytes in PTSD suggests chronic immune activation. Psychosomatics.

1999;40(3):222-5.

o Woolley CS, Gould E, McEwen BS. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res.

1990;531(1-2):225-31.

o Yamada S,Yamamoto M, Ozawa H, Riederer P, Saito T. Reduced

phosphorylation of cyclic AMP-responsive element binding protein in the

postmortem orbitofrontal cortex of patients with major depressive disorder. J

Neural Transm. 2003;110: 671–680.

(19)

o Yehuda R, Bierer LM, Schmeidler J, Aferiat DH, Breslau I, Dolan S. Low cortisol and risk for PTSD in adult offspring of holocaust survivors. Am J Psychiatry. 2000;157(8):1252-9.

o Yehuda R, Blair W, Labinsky E, Bierer LM. Effects of parental PTSD on the cortisol response to dexamethasone administration in their adult offspring. Am J Psychiatry. 2007;164(1):163-6.

o Yehuda R, Boisoneau D, Lowy MT, Giller EL Jr. Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Arch Gen Psychiatry. 1995;52(7):583-93.

o Yehuda R, Brand SR, Golier JA, Yang RK. Clinical correlates of DHEA associated with post-traumatic stress disorder. Acta Psychiatr Scand.

2006;114(3):187-93.

o Yehuda R, Kahana B, Binder-Brynes K, Southwick SM, Mason JW, Giller EL.

Low urinary cortisol excretion in Holocaust survivors with posttraumatic stress disorder. Am J Psychiatry. 1995;152(7):982-6.

o Yehuda R, Levengood RA, Schmeidler J, Wilson S, Guo LS, Gerber D. Increased pituitary activation following metyrapone administration in post-traumatic stress disorder. Psychoneuroendocrinology. 1996;21(1):1-16.

o Yehuda R, Schmeidler J, Wainberg M, Binder-Brynes K, Duvdevani T.

Vulnerability to posttraumatic stress disorder in adult offspring of Holocaust survivors. Am J Psychiatry. 1998;155(9):1163-71.

o Yehuda R. Biological factors associated with susceptibility to posttraumatic stress disorder. Canadian Journal of Psychiatry, 1999; 44(1): 34-9.

o Yehuda R. Biology of posttraumatic stress disorder. J Clin Psychiatry. 2001;62 Suppl 17:41-6. Review.

o Yehuda R. Clinical relevance of biologic findings in PTSD. Psychiatric Quarterly, 2002;73:2.

o Yin JC, Del Vecchio M, Zhou H, Tully T. CREB as a memory modulator:

induced expression of a dCREB2 activator isoform enhances long-term memory in Drosophila. Cell. 1995;81(1):107-15.

o Yin JC, Wallach JS, Del Vecchio M, Wilder EL, Zhou H, Quinn WG, Tully T.

Induction of a dominant negative CREB transgene specifically blocks long-term memory in Drosophila. Cell. 1994;79(1):49-58.

o Yin JC, Wallach JS, Wilder EL, Klingensmith J, Dang D, Perrimon N, Zhou H,

Tully T, Quinn WG. A Drosophila CREB/CREM homolog encodes multiple

isoforms, including a cyclic AMP-dependent protein kinase-responsive

transcriptional activator and antagonist. Mol Cell Biol. 1995;15(9):5123-30.